2-Deoxy- d -Glucose (2-DG)-Induced Cardiac Toxicity in Rat

International Journal of Toxicology

Volumn 35, Issue 3, 2016, Pages 284-293

  Terse, P S ^a   Joshi, P S ^a   Bordelon, N R ^b,c   Brys, A M ^b   Patton, K M ^b   Arndt, T P ^b,d   Sutula, T P ^e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c Covance ^*  (United States)

^d 206 Carnegie Center   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

2 deoxy d glucose; BNP; NT proBNP; vacuolar degeneration

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; DEOXYGLUCOSE; TROPONIN I; TROPONIN T; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CARDIOTOXICITY; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; ENDOCARDIUM; ENDOTHELIUM CELL; FEMALE; HEART HYPERTROPHY; HEART INJURY; HISTOPATHOLOGY; MALE; NONHUMAN; RAT; ANIMAL; BLOOD; CARDIAC MUSCLE; CARDIOMEGALY; CHEMICALLY INDUCED; DRUG EFFECTS; FISCHER 344 RAT; HEART; PATHOLOGY;

ANIMALS; BIOMARKERS; CARDIOMEGALY; DEOXYGLUCOSE; FEMALE; HEART; MALE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RATS; RATS, INBRED F344; VACUOLES;

EID: 84966686833     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581815624397     Document Type: Article

References (27)

1. Vamecq J, Vallée L, Lesage F, Gressens P, Stables JP,. Antiepileptic popular ketogenic diet: emerging twists in an ancient story. Prog Neurobiol. 2005; 75 (1): 1-28.
2. Stafstrom CE, Ockuly JC, Murphree L, Valley MT, Roopra A, Sutula TP,. Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models. Ann Neurol. 2009; 65 (4): 435-447.
3. Huttenlocher PR,. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr Res. 1976; 10 (5): 536-540.
4. Hu XL, Cheng X, Fei J, Xiong ZQ,. Neuron-restrictive silencer factor is not required for the antiepileptic effect of the ketogenic diet. Epilepsia. 2011; 52 (9): 1609-1616.
5. Garriga-Canut M, Schoenike B, Qazi R, et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci. 2006; 9 (11): 1382-1387.
6. Horton RW, Meldrum BS, Bachelard HS,. Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose. J Neurochem. 1973; 21 (3): 507-520.
7. Minor RK, Smith DL Jr, Sossong AM, et al. Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats. Toxicol Appl Pharmacol. 2010; 243 (3): 332-339.
8. Singh V, Martinezclark P, Pascual M, Shaw ES, O'Neill WW,. Cardiac biomarkers-the old and the new: a review. Coron Artery Dis. 2010; 21 (4): 244-256.
9. Dietz JR,. Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovasc Res. 2005; 68 (1): 8-17.
10. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM,. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol. 2009;(191): 341-366.
11. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation. 1996; 93 (11): 1963-1969.
12. Kang YJ,. Toxic responses of the heart and vascular system. In: Klaassen CD, ed. Casarett and Doull's Toxicology. The Basic Science of Poisons. Blacklick, OH: The McGraw-Hill Companies, Inc; 2008: 699-740.
13. Thygesen K, Alpert JS, White HD,. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007; 50 (22): 2173-2195.
14. Takeda S, Yamashita A, Maeda K, Maeda Y,. Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form. Nature. 2003; 424 (6944): 35-41.
15. Perry SV,. Troponin I: inhibitor or facilitator. Mol Cell Biochem. 1999; 190 (1-2): 9-32.
16. Nanji AA,. Serum creatine kinase isoenzymes: a review. Muscle Nerve. 1983; 6 (2): 83-90.
17. Adamcova M, Sterba M, Simunek T, et al. Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity. Expert Opin Drug Saf. 2005; 4 (3): 457-472.
18. Hessel MH, Michielsen EC, Atsma DE, et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol. 2008; 85 (2): 90-95.
19. Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J,. Assessment of anthracycline-induced cardiotoxicity with biochemical markers. Exp Oncol. 2007; 29 (4): 309-313.
20. Sorodoc V, Sorodoc L, Ungureanu D, Sava A, Jaba IM,. Cardiac troponin T and NT-proBNP as biomarkers of early myocardial damage in amitriptyline-induced cardiovascular toxicity in rats. Int J Toxicol. 2013; 32 (5): 351-357.
21. De Lemos JA, McGuire DK, Drazner MH,. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003; 362 (9380): 316-322.
22. Weber M, Hamm C,. Role of B-type natriuretic peptide (BNP) and NTproBNP in clinical routine. Heart. 2006; 92 (6): 843-849.
23. Romano S, Fratini S, Ricevuto E, et al. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer. 2011; 105 (11): 1663-1668.
24. Vijayaraghavan R, Kumar D, Dube SN, et al. Acute toxicity and cardio-respiratory effects of 2-deoxy-D-glucose: a promising radio sensitiser. Biomed Environ Sci. 2006; 19 (2): 96-103.
25. Pandey R, Choudhry PK, Deshpande SB,. 2-Deoxy-D-glucose alters the cardio-respiratory parameters in anaesthetized rats. Indian J Physiol Pharmacol. 2008; 52 (3): 243-248.
26. Gaggin HK, Januzzi JL Jr,. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta. 2013; 1832 (12): 2442-2450.
27. Lane MA, Ingram DK, Roth GS,. 2-Deoxy-D-glucose feeding in rats mimics physiological effects of calorie restriction. J Anti-Aging Med. 1998; 1 (4): 327-337.